In line with our focus this month on all aspects of influenza, we spoke to Ed Schmidt, project manager of the Universal Influenza Vaccines Secured (UNISEC) consortium, about its aim to develop a universal flu vaccine.
Browsing: Clinical > Vaccines
Researchers have reported an acceptable safety and immunogenicity profile of an Ebola vaccine in adults and potentially in children in Africa – indicating that the vaccine produces an immune response and is considered safe.
A new DNA-based Zika vaccine, GLS-5700, has been reported as safe and immunogenic in Phase I trial, according to new research.
Researchers have demonstrated the having a positive mood on the day of flu vaccination may predict and even improve vaccine effectiveness.
Read our report covering the Knowledge Transfer Network’s vaccine development and manufacture event, focusing on the future innovation landscape for the UK and covering topics from new technologies to scale-down models for producing cheaper vaccines.
In this report we look at the burden of cryptococcal meningitis, issues with current treatment regimens and future research directions.
A study has suggested that the current strategies aimed at changing perceptions towards measles, mumps and rubella vaccinations only serve to reinforce these false beliefs.
In this interview, we discuss public health and music playlists with Natasha Crowcroft, Chief of Applied Immunization Research and Evaluation at Public Health Ontario and Professor in Laboratory Medicine and Pathobiology and the Dalla Lana School of Public Health at the University of Toronto.
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.